• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg

Lindahl assists Nanexa in a preferential rights issue

  • Home
  • Latest news
  • Cases and transactions
  • 2021
  • Lindahl assists Nanexa in a preferential rights issue

On 7 June 2021, Nanexa AB (Plc.) decided to conduct a preferential rights issue of shares worth approximately SEK 126.7 million. The preferential rights issue is fully covered by subscription commitments and guarantee commitments. In addition, the Board of Directors may decide to implement an over-allotment issue in the form of a directed issue of a maximum of approx. SEK 23.5 million, provided that the preferential rights issue is fully subscribed.

Nanexa AB is a nanotechnological drug delivery company focused on the development of PharmaShell®, a new and groundbreaking drug delivery system with great potential in a number of substance types and indication areas. Within the context of PharmaShell®, Nanexa develops its own projects and has cooperation agreements with several pharmaceutical companies. Nanexa’s shares are listed on the Nasdaq First North Growth Market.

Lindahl has advised Nanexa with a team consisting of Gunnar Mattsson, Michael Edquist, Erika Svensson and Erik Vikström, among others. ABG Sundal Collier has acted as the sole global coordinator and bookrunner.

Contact

  • Gunnar Mattsson

    Uppsala

    gunnar.mattsson@lindahl.se +46 708 161 869
  • Michael Edquist

    Uppsala

    michael.edquist@lindahl.se +46 705 661 879
  • Erika Svensson

    Uppsala

    erika.svensson@lindahl.se +46 704 215 839
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience